Open Access. Powered by Scholars. Published by Universities.®
Other Pharmacy and Pharmaceutical Sciences Commons™
Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Chemicals and Drugs (206)
- Other Chemicals and Drugs (188)
- Life Sciences (30)
- Pharmaceutics and Drug Design (27)
- Diseases (26)
-
- Medicinal and Pharmaceutical Chemistry (21)
- Amino Acids, Peptides, and Proteins (17)
- Medical Specialties (15)
- Cell and Developmental Biology (13)
- Natural Products Chemistry and Pharmacognosy (12)
- Oncology (11)
- Physical Sciences and Mathematics (10)
- Public Health (10)
- Analytical, Diagnostic and Therapeutic Techniques and Equipment (8)
- Animal Experimentation and Research (7)
- Cancer Biology (7)
- Cell Biology (7)
- Medical Education (7)
- Medical Sciences (7)
- Research Methods in Life Sciences (7)
- Therapeutics (7)
- Chemistry (6)
- Nervous System Diseases (6)
- Cardiovascular Diseases (5)
- Education (5)
- Pharmacy Administration, Policy and Regulation (5)
- Bacterial Infections and Mycoses (4)
- Institution
-
- University of Kentucky (191)
- Chapman University (55)
- Universitas Indonesia (12)
- University of Nebraska Medical Center (6)
- University of AlKafeel (4)
-
- Illinois State University (2)
- Nova Southeastern University (2)
- Technological University Dublin (2)
- University of Montana (2)
- Belmont University (1)
- Duquesne University (1)
- Florida Institute of Technology (1)
- Marshall University (1)
- Purdue University (1)
- Roseman University of Health Sciences (1)
- Saint Louis University School of Law (1)
- St. John Fisher University (1)
- University of Connecticut (1)
- University of Louisville (1)
- University of Mississippi (1)
- University of New Hampshire (1)
- University of South Carolina (1)
- University of Texas at Arlington (1)
- Virginia Commonwealth University (1)
- Keyword
-
- Aluminum in foods (134)
- Aluminum content (52)
- Fats (27)
- Molasses (27)
- Oils (27)
-
- Sugar (27)
- Syrup (27)
- Vinegar (27)
- Yeast (27)
- Aluminum in food (26)
- Baking powder (26)
- Baking soda (26)
- Eggs (26)
- Honey (26)
- Oxidative stress (4)
- Antioxidant (3)
- Breast cancer (3)
- Drug delivery (3)
- Obesity (3)
- Pharmacogenomics (3)
- Alcohol (2)
- Antibiotics (2)
- Antimicrobial (2)
- Antimicrobial peptides (2)
- Immunotherapy (2)
- Liver (2)
- Mass spectrometry (2)
- Mechanism of action (2)
- Metabolic syndrome (2)
- Pharmacists (2)
- Publication
-
- Aluminum in Beverages and Foods: A Compilation (186)
- Pharmacy Faculty Articles and Research (45)
- Pharmaceutical Sciences and Research (11)
- Theses & Dissertations (6)
- Maaen Journal for Medical Sciences (4)
-
- Pharmaceutical Sciences (PhD) Dissertations (3)
- Theses and Dissertations--Pharmacy (3)
- Biology, Chemistry, and Environmental Sciences Faculty Articles and Research (2)
- Electronic Theses and Dissertations (2)
- Graduate Student Theses, Dissertations, & Professional Papers (2)
- Markey Cancer Center Faculty Publications (2)
- Pharmaceutical Sciences (MS) Theses (2)
- Theses and Dissertations (2)
- All Faculty Scholarship (1)
- Annual Research Symposium (1)
- Annual Symposium on Biomathematics and Ecology Education and Research (1)
- DNP Scholarly Projects (1)
- Department of Nutrition Student Projects (1)
- Dissertations (1)
- Doctor of Nursing Practice (DNP) Scholarly Projects - Archive (1)
- Eric M. Scandrett Graduate Library Research Prize (1)
- Honors Scholar Theses (1)
- Honors Theses (1)
- Internet Journal of Allied Health Sciences and Practice (1)
- Library Presentations, Posters, and Audiovisual Materials (1)
- Makara Journal of Science (1)
- SURE Journal: Science Undergraduate Research Experience Journal (1)
- Science University Research Symposium (SURS) (1)
- Senior Theses (1)
- Soaring: A Journal of Undergraduate Research (1)
- Publication Type
- File Type
Articles 271 - 291 of 291
Full-Text Articles in Other Pharmacy and Pharmaceutical Sciences
The Complex Protein Analysis Of Purified Extracellular Vesicles In The Study Of Colorectal Cancer, Renee Boone, Cecilia Osthoff
The Complex Protein Analysis Of Purified Extracellular Vesicles In The Study Of Colorectal Cancer, Renee Boone, Cecilia Osthoff
Science University Research Symposium (SURS)
Proteomics, the study of complex protein mixtures in which liquid chromatography-mass spectrometry (LC-MS) is used to analyze peptide sequences, is commonly utilized to study the double membrane, cell-derived vesicles known as exosomes. Exosomes are double membrane, cell-derived vesicles that contain cell components such as DNA, lipids, and proteins. They function to transport proteins and cellular materials between cells and are involved in the progression and metastasis of cancer. The impact of these extracellular vesicles on cancer spread can be analyzed using proteomics, through the purification of the proteins isolated from the vesicles. The purpose of our research is to analyze …
Wine, Sparkling, Robert Yokel
Wine, Sparkling, Robert Yokel
Aluminum in Beverages and Foods: A Compilation
No abstract provided.
Wine, Other, Robert Yokel
Wine, Other, Robert Yokel
Aluminum in Beverages and Foods: A Compilation
No abstract provided.
Table B: Generally Recognized As Safe (Gras) Food Additives Containing Aluminum, Robert Yokel
Table B: Generally Recognized As Safe (Gras) Food Additives Containing Aluminum, Robert Yokel
Aluminum in Beverages and Foods: A Compilation
No abstract provided.
Mineral, Spring, Table, And Bottled Water, Robert Yokel
Mineral, Spring, Table, And Bottled Water, Robert Yokel
Aluminum in Beverages and Foods: A Compilation
No abstract provided.
Liquors And Spirits, Robert Yokel
Liquors And Spirits, Robert Yokel
Aluminum in Beverages and Foods: A Compilation
No abstract provided.
Wine, Red, Robert Yokel
Wine, Red, Robert Yokel
Aluminum in Beverages and Foods: A Compilation
No abstract provided.
Wine, White, Robert Yokel
Wine, White, Robert Yokel
Aluminum in Beverages and Foods: A Compilation
No abstract provided.
Table D: Aluminum-Containing Additives Allowed By The Eu And Fao/Who, Robert Yokel
Table D: Aluminum-Containing Additives Allowed By The Eu And Fao/Who, Robert Yokel
Aluminum in Beverages and Foods: A Compilation
No abstract provided.
Table C: Some Other Fda-Approved Sources Of Aluminum In Food, Robert Yokel
Table C: Some Other Fda-Approved Sources Of Aluminum In Food, Robert Yokel
Aluminum in Beverages and Foods: A Compilation
No abstract provided.
Table E: Aluminum Lakes Of Permitted Colors Allowed By The European Union, Robert Yokel
Table E: Aluminum Lakes Of Permitted Colors Allowed By The European Union, Robert Yokel
Aluminum in Beverages and Foods: A Compilation
No abstract provided.
Cardiometabolic Genomics And Pharmacogenomics In Filipino Americans: A Cross-Sectional Study, Khalifa Y. Alrajeh
Cardiometabolic Genomics And Pharmacogenomics In Filipino Americans: A Cross-Sectional Study, Khalifa Y. Alrajeh
Theses and Dissertations
Background: Heart disease remains a leading cause of death in the country, with significant ethnic disparities. Filipino Americans (FAs), the third-largest Asian subgroup in U.S., face an elevated burden of dyslipidemia, a primary modifiable risk factor for heart disease. Objectives: This community-based study addresses critical knowledge gaps by characterizing the cardiometabolic and genetic factors contributing to dyslipidemia among FAs and implications for personalized cardiovascular drug therapies, particularly statin pharmacogenomics (PGx). Methods: We characterized dyslipidemia prevalence in FAs and major ethnic subgroups using nationally representative NHANES data. We examined associations between uric acid (UA) levels and lipid profiles, …
Enhancing Safety Surveillance During Clinical Trials: The Development Of A Safety Data Review Handbook To Support Pharmacovigilance Clinicians, Lauren Wilson
DNP Scholarly Projects
Abstract
BACKGROUND: Pharmacovigilance (PV) Sciences include activities related to safety surveillance of pharmaceutical products, and is critical for developing safe and effective medications, vaccines and medical devices. Safety monitoring starts with preclinical research and continues through clinical trial and post marketing phases. PV scientists ensure patient safety during clinical trials through regular review and analysis of safety data. Regulations have become increasingly complex, leading to inadequately defined methods for reviewing large clinical trial safety datasets. Inconsistent safety data review (SDR) practices can result in delayed detection of adverse drug reactions (ADRs) or safety signals.
METHODS: This quality improvement project used …
Home Blood Pressure Monitoring Bundle For Hypertension Outcomes In Adult Patients Receiving Care In Public Health Clinics, Christine Jennifer Victorian
Home Blood Pressure Monitoring Bundle For Hypertension Outcomes In Adult Patients Receiving Care In Public Health Clinics, Christine Jennifer Victorian
Doctor of Nursing Practice (DNP) Scholarly Projects - Archive
Background: Hypertension (HTN) that is not adequately controlled leads to cardiovascular disease, stroke, and heart disease. It affects 116 million adults (47%) in the United States (U.S.). The HTN compliance rate in a South Texas public health clinic was 64%, below the national benchmark of 76%. Home blood pressure monitoring (HBPM) was recommended in a joint statement by the American Heart Association (AHA) and the American Medical Association (AMA). Literature evidence revealed that the HBPM bundle increased BP control (< 140/90 mmHg) compliance.
Methods: A quality improvement (QI) bundle was initiated to address the low HTN compliance rate from a quality management perspective. …
Sensitizing Keap1 Loss Non-Small Cell Lung Cancer To Artesunate Anti-Cancer Activity, Keng Hee Peh
Sensitizing Keap1 Loss Non-Small Cell Lung Cancer To Artesunate Anti-Cancer Activity, Keng Hee Peh
Theses and Dissertations--Pharmacy
Lung cancer is the global leading cause of cancer related death. Non-small cell lung cancer (NSCLC) accounts for 80% of lung cancer diagnoses conferring a significant disease burden. However, certain mutations in tumor suppressors such as Kelch-like ECH-associated protein 1 (KEAP1) confers resistance to standard of care therapy in NSCLC. KEAP1 is known to regulate multiple cellular processes such as oxidative stress response and anti-apoptotic pathways. Furthermore, KEAP1 loss of function in NSCLC is associated with poorer clinical outcomes and there are no currently approved therapies for KEAP1 loss NSCLC and represents an unmet clinical need. Artesunate (Art) demonstrated anti-cancer …
Inhibiting Pi3k/Akt To Enhance Brain Uptake Of Anticancer Agents In Glioblastoma, Louis Rodgers
Inhibiting Pi3k/Akt To Enhance Brain Uptake Of Anticancer Agents In Glioblastoma, Louis Rodgers
Theses and Dissertations--Pharmacy
Glioblastoma (GBM) is the deadliest and most common malignant CNS tumor. Despite advances in understanding its biology and the development of targeted therapies, effective treatment options remain limited. As a result, patient survival rates are dismal, with a 5-year survival rate of only 6.8% and an overall survival of less than two years. This poor outcome is partly due to our inability to treat GBM cells that infiltrate the whole brain. Focal treatments like surgery and radiotherapy alone are insufficient due to these invasive tumor cells. Therefore, chemotherapy following resection and irradiation of the primary tumor is essential to eliminate …
Carfilzomib-Loaded Ternary Polypeptide Nanoparticles Stabilized By Polycationic Complexation, Preye Mike Agbana, Ji Eun Park, Piotr G. Rychahou, Kyung-Bo Kim, Younsoo Bae
Carfilzomib-Loaded Ternary Polypeptide Nanoparticles Stabilized By Polycationic Complexation, Preye Mike Agbana, Ji Eun Park, Piotr G. Rychahou, Kyung-Bo Kim, Younsoo Bae
Markey Cancer Center Faculty Publications
Carfilzomib (CFZ) is a second-generation proteasome inhibitor showing great efficacy in multiple myeloma treatment, yet its clinical applications for other diseases such as solid cancers are limited due to low aqueous solubility and poor biostability. Ternary polypeptide nanoparticles (tPNPs) are drug carriers that we previ- ously reported to overcome these pharmaceutical limitations by entrapping CFZ in the core of the nanopar- ticles and protecting the drugs from degradation in biological media. However, preclinical studies revealed that tPNPs would require further improvement in particle stability to suppress initial burst drug release and thus achieve prolonged inhibition of proteasome activity with CFZ …
Perspectives On Using Pharmacogenomics To Guide Tobacco Cessation: Survey Results From An American Indian Community, Daniela Mariana Wall
Perspectives On Using Pharmacogenomics To Guide Tobacco Cessation: Survey Results From An American Indian Community, Daniela Mariana Wall
Graduate Student Theses, Dissertations, & Professional Papers
Pharmacogenomics research has predominantly focused on populations of European ancestry, limiting the application for diverse populations such as American Indian and Alaska Native (AIAN) communities. Our community-centric study aims to understand perspectives of utilizing pharmacogenomics to guide tobacco cessation in an AIAN community using a survey with qualitative and quantitative components. We assessed participant (n=273) tobacco usage and cessation history, pharmacogenomics knowledge, and perceptions of utilizing pharmacogenomics in the context of tobacco cessation. We found that the majority of participants (92%) were aware of risks associated with tobacco usage and believe it to be a problem within their community (76%). …
Perspectives Of Utilizing Pharmacogenomics To Inform Tobacco Cessation: Survey Results From An American Indian Community, Madeline Lousie Davies
Perspectives Of Utilizing Pharmacogenomics To Inform Tobacco Cessation: Survey Results From An American Indian Community, Madeline Lousie Davies
Graduate Student Theses, Dissertations, & Professional Papers
Pharmacogenomics research has predominantly focused on populations of European ancestry, limiting the application for diverse populations such as American Indian and Alaska Native (AIAN) communities. Our community-centric study aims to understand perspectives of utilizing pharmacogenomics to guide tobacco cessation in an AIAN community using a survey with qualitative and quantitative components. We assessed participant (n=273) tobacco usage and cessation history, pharmacogenomics knowledge, and perceptions of utilizing pharmacogenomics in the context of tobacco cessation. We found that the majority of participants (92%) were aware of risks associated with tobacco usage and believe it to be a problem within their community (76%). …
Ai Renaissance: Pharmaceuticals And Diagnostic Medicine, Ty J. Feeney, Michael S. Sinha
Ai Renaissance: Pharmaceuticals And Diagnostic Medicine, Ty J. Feeney, Michael S. Sinha
All Faculty Scholarship
The explosive growth of Artificial Intelligence (AI) in the modern era has led to significant advancements in the world of medicine. In drug discovery, AI technology is used to classify proteins as drug targets or non-targets for specific diseases, more accurately interpret and describe pharmacology in a quantitative fashion, and predict protein structures based on only a protein sequence for input. AI methods are used in drug development to generate predictive models for drug screening purposes, refine and modify candidate structures of drugs to optimize compounds, and predict a drug’s physiochemical properties, bioactivity, and toxicity. For medical devices, the advancement …
Enhancing Organisational Performance Through Patient-Focused Learning Excellence In The Biopharmaceutical Industry, Lori Richter
Enhancing Organisational Performance Through Patient-Focused Learning Excellence In The Biopharmaceutical Industry, Lori Richter
Dissertations
Drug shortages, quality defects and challenges regarding innovation within the biopharmaceutical industry pose significant risks to patient safety and organisational performance. These problems persist despite the many scientific, technological and economic advances over the past several years in a well-funded, high-revenue industry operated by highly qualified personnel. Evidence suggests that the industry has yet to fully realise the potential for building organisational capabilities to enable learning from mistakes to enhance performance outcomes. This research study explored how biopharmaceutical companies can learn from their mistakes and embrace a culture of learning in order to reduce quality defects and drug shortages by …